Doctor profile · Federal record
Dr. FAYSAL AL-GHOULA, MBBCH
Pulmonary Disease Physician (CMS: PULMONARY DISEASE) · Internal Medicine Physician · Pulmonary Disease Physician · ROCHESTER, MN
- NPI 1477008670
- Accepts Medicare
- 14 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
200 1ST ST SW
ROCHESTER, MN 559050001
(507) 284-2511 - Additional location
-
601 N 30th St, CU Department of medicine
Omaha, NE 681312128
(402) 717-0800
Credentials & registration
- NPI registered
- August 2016 — 10 yrs on file
- Profile last updated
- January 15, 2024
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (3)
- Indiana #01090523A · Nebraska #7852 · Minnesota #67116
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477008670. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
30
Distinct HCPCS
1
Medicare allowed
$2,263
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 30 | 18 | $75 |
In context: peer comparison
Among 48 peers in this city , average services per provider: 57. This provider delivers 0.5× the peer median.Open Payments
Industry payments received
All-time total
$591
Transactions
27
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $165.80 | |
| GlaxoSmithKline, LLC. | 9 | $160.80 | |
| Mylan Specialty L.P. | 3 | $88.92 | |
| United Therapeutics Corporation | 1 | $74.45 | |
| Ethicon Inc. | 1 | $30.21 | |
| Amgen Inc. | 1 | $19.69 | |
| Insmed, Inc. | 1 | $18.04 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16.41 | |
| Grifols USA, LLC | 1 | $16.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
13
Patients
0
Total drug cost
$5,414
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 13 | 0 | $5,414 |